CDKN2C and cancer: CDKN2C was identified to participate in the occurrence and/or development of and play essential roles in multiple cancers such as esophageal squamous cell carcinoma [10], liver hepatocellular carcinoma (LIHC) [8], and lung adenocarcinoma (LUAD) [11].